Veracyte
VCYT
58 hedge funds and large institutions have $77.5M invested in Veracyte in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
50% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 14
5% more funds holding
Funds holding: 55 → 58 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $82.4M → $77.5M (-$4.91M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1.24M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
51
Panagora Asset Management
Boston,
Massachusetts
| $11K | – | – | – |
|
|
SO
52
STRS Ohio
Columbus,
Ohio
| $9K | – | – | – |
|
53
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $5K | -$14.3K | -2,661 | -72% |
|
54
BNP Paribas Financial Markets
Paris,
France
| $2.81K | +$2.99K | +558 | New |
|
55
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
TRCT
56
Tower Research Capital (TRC)
New York
| $2K | +$2K | +372 | New |
|
57
BlackRock
New York
| $1K | +$611 | +114 | +65% |
|
58
Bank of America
Charlotte,
North Carolina
| $1K | +$1.42K | +264 | New |
|
|
DM
59
Deerfield Management
New York
| – | -$892K | -165,097 | Closed |
|
|
CAM
60
Cormorant Asset Management
Boston,
Massachusetts
| – | -$745K | -137,990 | Closed |
|
|
BC
61
Broadfin Capital
New York
| – | -$525K | -97,298 | Closed |
|
|
FG
62
Formula Growth
Montreal,
Quebec, Canada
| – | -$350K | -64,785 | Closed |
|
VCYT Hedge Fund Activity: Q2 2016 in Review
58 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2016, worth a combined $77.5M — down 6% from $82.4M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new VCYT positions and 4 closed out — a net gain of 3 holders — while 21 added to existing stakes and 14 trimmed.
The largest buyer was Acuta Capital Partners, adding an estimated $2.42M. The largest seller was Clough Capital Partners, cutting an estimated $3.48M.
- 58 institutional investors held Veracyte (VCYT) as of Q2 2016, up from 55 in Q1 2016.
- Funds reported $77.5M of Veracyte stock for Q2 2016, down 6% quarter-over-quarter.
- 7 funds opened new Veracyte positions in Q2 2016 and 4 closed out, a net change of +3 holders.
- The largest Veracyte buyer in Q2 2016 was Acuta Capital Partners, an estimated $2.42M added.
- The largest Veracyte seller in Q2 2016 was Clough Capital Partners, an estimated $3.48M sold.
Based on aggregated 13F filings for Q2 2016.